Cancer as an evolutionary process at the cell level: an epidemiological perspective

Area of Science:

• Oncology
• Genetics
• Evolutionary Biology

Background:

• Germ-line mutations in cell cycle genes cause cancer in specific cell types.
• A 'mutator phenotype' is not essential for sporadic cancers; further selective events are required for malignancy.
• Immune impairment does not broadly cause cancer, suggesting cell-specific factors are crucial.

Purpose of the Study:

• To propose a new theory of carcinogenesis based on genetic change and selective advantage.
• To explain variations in cancer rates and migrant cancer risk through gene-environment interactions.
• To re-interpret carcinogenesis in light of neo-Darwinian evolutionary principles.

Main Methods:

• Analysis of existing data on germ-line mutations, cancer incidence, and immune function.
• Comparison of cancer rates in different countries and among migrant populations.
• Theoretical modeling of carcinogenesis as a two-phase process (genetic change and clone expansion).

Main Results:

• Cancer development requires cell-specific events beyond initial mutations.
• Selective pressures, such as resistance to apoptosis or environmental adaptation, drive cancer progression.
• Gene-environment interactions, influenced by a cell's genetic history and environment, are key to carcinogenesis.

Conclusions:

• Carcinogenesis involves genetic alteration followed by selection, analogous to evolution.
• Environmental factors and gene-environment interactions play a critical role in cancer development by promoting mutated cell survival.
• Understanding these selective pressures is vital for explaining cancer incidence variations and developing targeted therapies.